Congenital hepatic fibrosis (a case report)

Authors

DOI:

https://doi.org/10.14739/2310-1210.2021.6.229102

Keywords:

congenital hepatic fibrosis, pregnancy, transient elastography, splenic artery, embolization

Abstract

Congenital hepatic fibrosis (CHF) is an autosomal recessive disorder of intrauterine morphogenesis of the portobiliary system, characterized by periportal fibrosis and defective remodeling of the bile ducts. The article describes the features of the clinical course, diagnosis and treatment of type I CHF in the different terms of a patient’s life: from birth to her pregnancy, during pregnancy and after childbirth.

The aim of this work is to familiarize specialists with the problem of diagnosis and treatment of type I CHF in a patient with a provisional misdiagnosis of cryptogenic liver cirrhosis.

Results. The features of type I CHF that determine a wider diagnostic testing in long-term unspecified liver pathology cases were identified. First-time decompensation of portal hypertension (PH) occurred at 35 weeks of gestation with the development of ascitic-edematous syndrome, hypersplenism, preeclampsia without signs of hepatic encephalopathy (HE). Cesarean section was performed at 37 weeks’ gestation and healthy baby was born. One year and 9 months after delivery, hypersplenism compensation was achieved by performing splenic artery embolization (SAE). There were no clinical manifestations of HE throughout the follow-up period.

Conclusions. The diagnostic algorithm for a long-term compensated unspecified liver pathology with PH should confirm or rule out CHF. Type I CHF patients can give birth to a healthy child. SAE successfully compensates for hypersplenism and PH in type I CHF. Transient elastography is an effective method for the assessment of liver fibrosis progression in patients with type I CHF.

 

Author Biographies

O. O. Popovych, Vinnytsia National Pirogov Memorial Medical University, Ukraine

MD, PhD, Associate Professor of the Department of Infection Diseases

L. V. Moroz, Vinnytsia National Pirogov Memorial Medical University, Ukraine

MD, PhD, DSc, Professor, Head of the Department of Infection Diseases

Yu. V. Avdosiev, State Institution “Institute of General and Emergency Surgery named after V. T. Zaycev of the National Academy of Medical Sciences of Ukraine”, Kharkiv

MD, PhD, DSc, Senior Researcher, Head of the Department of X-ray and Surgery

F. A. Chabanov, Vinnytsia City Clinical Hospital No. 1, Ukraine

MD, infectious disease specialist of the highest category

O. O. Voinalovych, Vinnytsia National Pirogov Memorial Medical University, Ukraine

MD, Assistant of the Department of Infection Diseases

References

Shorbagi, A., & Bayraktar, Y. (2010). Experience of a single center with congenital hepatic fibrosis: a review of the literature. World Journal of Gastroenterology, 16(6), 683-690. https://doi.org/10.3748/wjg.v16.i6.683

Alsomali, M. I., Yearsley, M. M., Levin, D. M., & Chen, W. (2020). Diagnosis of Congenital Hepatic Fibrosis in Adulthood. American Journal of Clinical Pathology, 153(1), 119-125. https://doi.org/10.1093/ajcp/aqz140

Lipschitz, B., Berdon, W. E., Defelice, A. R., & Levy, J. (1993). Association of congenital hepatic fibrosis with autosomal dominant polycystic kidney disease. Report of a family with review of literature. Pediatric Radiology, 23(2), 131-133. https://doi.org/10.1007/BF02012406

Zerres, K., Mücher, G., Becker, J., Steinkamm, C., Rudnik-Schöneborn, S., Heikkilä, P., Rapola, J., Salonen, R., Germino, G. G., Onuchic, L., Somlo, S., Avner, E. D., Harman, L. A., Stockwin, J. M., & Guay-Woodford, L. M. (1998). Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology. American Journal of Medical Genetics, 76(2), 137-144.

Alhaddad, O. M., Elsabaawy, M. M., Shaarawy, O. A., Ehsan, N. A., Maher, D., Alazab, D., & Rewisha, E. A. (2017). Congenital Hepatic Fibrosis (CHF): A Report of Two Cases and an Overview. Annals of Clinical and Laboratory Research, 5(1), Article 152. https://doi.org/10.21767/2386-5180.100015

Zeitoun, D., Brancatelli, G., Colombat, M., Federle, M. P., Valla, D., Wu, T., Degott, C., & Vilgrain, V. (2004). Congenital Hepatic Fibrosis: CT Findings in 18 Adults. Radiology, 231(1), 109-116. https://doi.org/10.1148/radiol.2311030108

Parkash, A., Cheema, H. A., Malik, H. S., & Fayyaz, Z. (2016). Congenital hepatic fibrosis: clinical presentation, laboratory features and management at a tertiary care hospital of Lahore. Journal of Pakistan Medical Association, 66(8), 984-988.

Perezpeña-Diazconti, M., Hernández-Plata, A., Acosta-Rodríguez, P., Flores-Armas, M., & Velásquez-Jones, L. (2014). Fibrosis hepática congénita: complicaciones y manejo. Boletín Médico del Hospital Infantil de México, 71(5), 307-314. https://doi.org/10.1016/j.bmhimx.2014.10.005

Bayraktar, Y., Tuncer, Z. S., Kabukçu, A., Uzunalimoğlu, B., & Ayhan, A. (1997). Pregnancy complicated by congenital hepatic fibrosis with cavernous transformation of the portal vein: A case report. American Journal of Obstetrics and Gynecology, 177(2), 459-461. https://doi.org/10.1016/s0002-9378(97)70216-3

Byrd, L. M. & Bullenb, P. (2005). Congenital hepatic fibrosis and portal hypertension in pregnancy. International Journal of Gynecology and Obstetrics, 88(2), 142-143. https://doi.org/10.1016/j.ijgo.2004.11.005

Grio, R., D'Addato, F., Nicolosi, M. G., Barbini, V., Colla, F., Attini, R., Leotta, E., & Lanza, A. (2002). Congenital hepatic fibrosis in pregnancy. Minerva Ginecologica, 54(6), 509-512.

Zhang, Y., Meng, Z., Li, Z., Wang, L., Qiu, S., & Xu, C. (2021). A pregnant woman with congenital hepatic fibrosis delivers a healthy neonate. Liver International, 41(1), 128-132. https://doi.org/10.1111/liv.14683

Elsayed, S. S., Shiha, G., Hamid, M., Farag, F. M., Azzam, F., & Awad, M. (1996). Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study. Gut, 38(5), 770-774. https://doi.org/10.1136/gut.38.5.770

Downloads

Published

2021-10-29

How to Cite

1.
Popovych OO, Moroz LV, Avdosiev YV, Chabanov FA, Voinalovych OO. Congenital hepatic fibrosis (a case report). Zaporozhye Medical Journal [Internet]. 2021Oct.29 [cited 2024Nov.5];23(6):882-8. Available from: http://zmj.zsmu.edu.ua/article/view/229102

Issue

Vol. 23 No. 6 (2021)

Section

Case Reports

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)